MoneyWorks4Me

Shree Ganesh Biotech (India) informs about disclosures

17 Sep 2022 Evaluate
Shree Ganesh Biotech (India) has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Savjani Enterprise.

The above information is a part of company’s filings submitted to BSE.
Peers